TrialClinical drug investigation2012

Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study.

Shehzad Ali et al.PubMed ↗Publisher ↗

No numbers read from the abstract.